Chris West's blog posts
Supporter stories Making the Cancer Taskforce’s recommendations a reality for blood cancer patients
This week, the independent Cancer Taskforce set out the six strategic priorities for achieving world-class cancer outcomes in England. But what does this mean for blood cancer patients, and what are our plans to deliver against these priorities?
Patient voices Launching our findings on Patient Need
On Tuesday evening, we invited 100 stakeholders from across the blood cancer arena to hear what patients have told us about their needs, and to begin the discussion about how the blood cancer sector responds to them.
Supporter stories CLL drug approved in Scotland
The SMC has approved the use of new drug venetoclax.
Supporter stories NICE publishes guidance for leukaemia treatment
The National Institute for Health and Care Excellence (NICE) has today published guidance on the use of the drug inotuzumab ozogamincin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia (ALL). Unfortunately for patients, they have not recommended the drug for routine use in the NHS in England.
Supporter stories NHS England confirms it will routinely commission second transplants
Today, NHS England has announced that it will make second allogeneic haematopoietic stem cell transplants routinely available to patients who have suffered a relapse.